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Abstract
Background: The Tec-family kinase Itk plays an important role during T-cell activation and
function, and controls also conventional versus innate-like T-cell development. We have
characterized the transcriptome of Itk-deficient CD3+ T-cells, including CD4+ and CD8+ subsets,
using Affymetrix microarrays.
Results: The largest difference between Itk-/- and Wt CD3+ T-cells was found in unstimulated cells,
e.g. for killer cell lectin-like receptors. Compared to anti-CD3-stimulation, anti-CD3/CD28
significantly decreased the number of transcripts suggesting that the CD28 co-stimulatory pathway
is mainly independent of Itk. The signatures of CD4+ and CD8+ T-cell subsets identified a greater
differential expression than in total CD3+ cells. Cyclosporin A (CsA)-treatment had a stronger
effect on transcriptional regulation than Itk-deficiency, suggesting that only a fraction of TCR-
mediated calcineurin/NFAT-activation is dependent on Itk. Bioinformatic analysis of NFAT-sites of
the group of transcripts similarly regulated by Itk-deficiency and CsA-treatment, followed by
chromatin-immunoprecipitation, revealed NFATc1-binding to the Bub1, IL7R, Ctla2a, Ctla2b, and
Schlafen1 genes. Finally, to identify transcripts that are regulated by Tec-family kinases in general,
we compared the expression profile of Itk-deficient T-cells with that of Btk-deficient B-cells and a
common set of transcripts was found.
Conclusion:  Taken together, our study provides a general overview about the global
transcriptional changes in the absence of Itk.
Background
The Tec family of non-receptor protein-tyrosine kinases
consists of five members (Bmx, Btk, Itk, Rlk/Txk and Tec);
T-cells express Itk, Rlk and Tec, and T-cell receptor (TCR)
stimulation leads to the activation of Tec family kinases
[1,2]. A large number of biochemical studies and the gen-
eration of mice that are single- or double-deficient for Itk,
Tec or Rlk have identified important roles, in particular for
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Itk, during T-cell development and activation, and in Th2
effector differentiation. Itk-/- mice show impaired positive
selection of CD4+ T-cells and it was suggested that Itk
modulates signaling thresholds during T-cell develop-
ment [3-5]. TCR signaling in naïve T-cells, and therefore
activation and proliferation, is impaired in the absence of
Itk, and Itk-/- T-cells show defective Th2 polarization [6].
Further, Itk regulates the actin cytoskeleton and is there-
fore necessary for proper synapse formation and for effi-
cient T-cell activation [7,8]. More recent data indicate that
Itk is involved in signaling pathways that regulate conven-
tional versus innate-like T-cell development. The majority
of CD8+ T-cells from Itk-/- as well as from Itk-/-Rlk-/- mice
show a more "innate-like" T-cell phenotype, sharing char-
acteristics with conventional memory T-cells, i.e. CD44hi,
CD62L- and CD122hi [9-11]. These cells depend on IL-15,
express TCRs specific for non-classical MHC class Ib mol-
ecules, and exhibit direct effector functions such as rapid
IFNγ production upon PMA/ionomycin stimulation [9-
12]. A significant fraction of innate-like CD44hiCD62L- T-
cells has also been described for the CD4+ T-cell lineage in
Itk-/- mice [13].
Biochemically, the defects in T-cell activation were linked
to an impaired phospholipase C-γ (PLCγ) phosphoryla-
tion and activation [5]. PLCγ hydrolyzes phosphatidyli-
nositol-4,5-biphosphate to produce inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG). IP3 induces
the release of intracellular calcium (Ca2+) thereby activat-
ing the serine/threonine phosphatase calcineurin. Itk acti-
vation results in high levels of IP3, which is required for
Ca2+  entry via store-operated channels leading to
increased Ca2+ in cells stimulated via the TCR [5]. Both
Ca2+ and calmodulin will bind and activate calcineurin,
which in turn dephosphorylates serines in the regulatory
domain of cytosolic NFAT. This induces a conformational
change in NFAT exposing nuclear localization signals
allowing its transport into the nucleus [14]. In Itk-defi-
cient T-cells the Ca2+-levels are reduced resulting in
impaired NFAT translocation [6]. Mice deficient in NFAT
family members share phenotypes with Tec kinase family-
deficient mice, as described by Lucas et al. [15]. The NFAT
family was first described as binding to and controlling
the interleukin 2 (IL-2) promoter and other lymphokine
promoters in T-cells [14]. The family consists of five mem-
bers; NFATc1–4 and NFAT5 [16,17]. Efficient inhibitors
for the activation of NFAT proteins have been developed.
Two of these, Cyclosporin A (CsA) and FK506, indirectly
inhibit NFAT by blocking the enzymatic activity of cal-
cineurin.
In order to further decipher the role of Itk we have inves-
tigated changes in gene expression of CD3+ as well as
CD4+ and CD8+ T-lymphocytes in normal and Itk-defec-
tive mice. The aim of the study was to (1) define the tran-
scriptome in unstimulated cells, (2) elucidate the
influence of anti-CD3 and anti-CD3/CD28-stimulation
and (3) to dissect which part of the observed alterations in
Itk-deficiency is dependent on the calcineurin/NFAT path-
way.
Methods
Mice and generation of T-cells
CD3+ as well as CD4+ and CD8+ T-cells from pooled sus-
pensions of spleen and lymph nodes of Wt and Itk-/- mice
on C57BL/6 background were isolated by negative deple-
tion; antibodies used are listed in Additional file 1. The
cell suspensions were incubated with the antibodies in
PBS supplemented with 2% FCS. Streptavidin beads (BD
Pharmingen) were used for negative depletion according
to manufacturer's instructions. The purity of the cells was
assessed by flow cytometry and was routinely >90%
CD3+, >96% CD4+ and >90% CD8+ T-cells. All animal
experiments were approved by the Federal Ministry for
Science and Research.
T-cell stimulations and Cyclosporin A treatment
Unstimulated as well as stimulated T-cells were studied.
Stimulations were performed in 48-well plates, coated
with anti-CD3 (1 μg/ml) with or without anti-CD28 (3
μg/ml) in the presence or absence of CsA (1 μg/ml) for 24
hrs. For each stimulus, at least duplicate samples were
used in all but one experiment. For the CD4+ T-cells we
collected triplicates from the Itk-/- mice and duplicates
from the Wt group. For the CD8+ T-cells, we got duplicates
from Itk-/-, while we obtained a single sample from Wt
owing to the low cell yield for resting Wt CD8+ T-cells.
After anti-CD3-stimulation we got a single sample from
the CD8+ subset of both Wt and Itk-/-, while for the CD4+
subsets we collected duplicates. To control if the number
of differentially expressed probe-sets was truthful in the
CD8+ subset, and not due to the lack of replicates, we ana-
lyzed the CD4+ in the same way as the CD8+ T-cells. The
results were consistent and we found the same number of
differentially expressed transcripts when single CD4+ sam-
ples were studied separately.
RNA isolation and microarray processing
RNA isolations were done according to RNeasy Mini pro-
tocol (Qiagen, Valencia, CA, USA) and microarray
processing as previously described [18]. The Affymetrix
MOE430 2.0 chips were used. In total 37 arrays were ana-
lyzed. The microarray data are accessible through the
Gene Expression Omnibus (GEO; GSE12466) [19,20].
Data and statistical analysis
The processing and primary data analysis was performed
in DNA-Chip Analyzer (dChip) [21]. In short, the invari-
ant set normalization method was used [22]. Thereafter,
model-based expression values were calculated according
to the perfect match (PM)-only model. The criterion for
fold-change analysis was set to ≥ 2-fold between groups.BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Signal values were then used in further statistical analysis
steps such as paired and unpaired Student t-test in Excel.
Some comparisons were performed using the chi square
(χ2) test. Immunoglobulin and histocompatibility tran-
scripts were excluded from the tables, since changes in
their expression may be secondary to events unrelated to
Itk-deficiency. Also the Xist and Tsix transcripts, X-chro-
mosome encoded and unique to females, as well as Y-spe-
cific mRNAs were removed owing to that we used mixed
sexes of mice in the experiments. One probe set that cor-
responded to Itk (1456836_at) was found to also be com-
plementary to an EST gene (recognized at Ensembl) [23]
and was therefore only included in the Additional mate-
rial. We manually annotated a group of genes on the basis
of prior knowledge about their role in the immune sys-
tem. The 900 probe-sets list of differentially expressed
transcripts between unstimulated Itk-/- and Wt T-cells was
used for this purpose. The classification resulted in 14
subgroups.
Validation of differentially expressed genes using 
quantitative RT-PCR
Total RNA (100 ng) was reversed-transcribed into cDNA
with AMV reverse transcriptase using random hexamer
primers (Roche Applied Science, IN, USA). TaqMan Gene
Expression Assays from Applied Biosystems were used to
confirm the microarray data and it was done as previously
described [24]. The validated genes were Klrg1
(Mm00516879_m1),  Klra3  (Mm01702813_m1) and
Klra7 (Mm01183384_m1). 18S rRNA was used as endog-
enous control.
Chromatin-immunoprecipitation for detection of NFATc1-
binding
Whole splenic and thymic cells were used for chromatin-
immunoprecipitation (ChIP) assay. The cells were lysed
by ammoniumchloride solution to remove erythrocytes,
counted and divided into three groups each. One group
was untreated, while the other two were treated with anti-
CD3ε(1 μg/ml) with or without pre-treatment of CsA (1
μg/ml) for 1 hour. The stimulated cells were incubated for
24 hrs in 37°C with 5% CO2. The protocol for ChIP was
described by Yu et al. [25] with the following modifica-
tions. After sonication and centrifugation, lysates were
incubated with 1 μg of polyclonal anti-NFATc1 (K-18)
antibody (sc-1149-R, Santa Cruz Biotechnology, Inc.) or
rabbit normal Ig overnight at 4°C with rotation. Identifi-
cation of targets was done by PCR using primers for the
genes corresponding to IL2, IL7R, Schlafen1, Bub1, Ctla2a
and Ctla2b (Additional file 2).
Results
Transcriptional changes in the absence of Itk in 
unstimulated CD3+ T-cells
In order to survey Itk-dependent transcriptional signa-
tures we initially conducted microarray analysis on
MACS-sorted CD3+ primary, unstimulated T-cells from
Itk-/- and Wt mice. The number of probe-sets changing ≥ 2-
fold in Itk-/- compared to Wt samples was 900 (2% of the
total number of probe-sets on the MOE 430 2.0 chips),
which is equivalent to 56% up- and 44% down-regulated
probe-sets (33% with p < 0.05). From the 900-list we
show the 60 most significantly up- and down-regulated
transcripts in Itk-deficiency (Table 1). Most up-regulated
were the killer cell lectin-like receptors Klra3 and Klra8,
followed by granzyme M. Oligoadenylate synthetase-like
2 (Oasl2) was the most down-regulated transcript, next
was actinin alpha 2 (Actn2). Furthermore, from the 900
probe-sets we have manually extracted 106 immune
response-related genes and divided them into 14 different
subgroups (Table 2). Of the 106 genes 10% were Klrs and
8.5% encoded transcription factors (Table 3). Additional
file 3 shows the individual genes in each category.
Transcriptional changes in the absence of Itk in stimulated 
CD3+ T-cells
Stimulating the Itk-/-  and Wt T-cells with anti-CD3
resulted in 804 differentially expressed probe-sets in Itk-
deficiency (74% up- and 26% down-regulated, 68% with
p < 0.05), while after anti-CD3/CD28-stimulation the
number was reduced to 409 (78% up- and 22% down-reg-
ulated; 58% with p < 0.05) as depicted in Figure 1a.
Between CD3- and CD3/CD28-stimulations, the overlap
was 252 probe-sets (see Table 4 for a list of the 60 most
up- and down-regulated transcripts). We show there that
Itk was the most down-regulated transcript in Itk-defi-
ciency, followed by Crabp2, which encodes cellular retin-
oic acid binding protein 2. This is a 15 kD regulator of
retinoic acid signaling recently reported to be differen-
tially expressed in acute lymphoblastic leukaemia [26].
Other down-regulated transcripts were IL-2 and IL-3.
Stimulation affected the majority of the transcripts in the
same direction as observed in unstimulated cells (p < 10-
6) (only in 5/252 cases the CD3- or CD3/CD28-stimula-
tions showed opposite fold-changes; Additional file 4).
We show there that the most induced mRNA was Klra8
(Ly49H) (21-fold-change upon anti-CD3-stimulation).
Other up-regulated Klrs were Klra3 (Ly49C), Klra5
(Ly49E), Klra7 (Ly49G), Klra19 (Ly49S), Klrc1 (NKG2A/
2B), Klrd1 (CD94), Klre1 (NKG2I) and Klrg1 (2P1-Ag).
By quantitative RT-PCR we confirmed the up-regulated
expression of Klrg1, Klra3 and Klra7 in Itk-defective sam-
ples (Fig. 1b). Two transcription factors, inhibitor of DNA
binding 2 (Id2) and eomesodermin, were also found up-
regulated. Thus, in CD3+ cells, differential transcriptional
signatures between Wt and Itk-deficient cells were more
pronounced in unstimulated when compared to activated
cells.
We continued to analyze the activation-dependent signa-
tures in Wt and Itk-/- T-cells separately. The number ofBMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Table 1: The 60 most up- and down-regulated transcripts in Itk-deficiency (unstimulated cells)
Probe set Gene Symbol, Gene Title Itk-/- vs Wt t-test
1453196_a_at Oasl2, 2'-5' oligoadenylate synthetase-like 2 -7.91 0.008
1448327_at Actn2, actinin alpha 2 -3.97 0.016
1437445_at Trpm1, transient receptor potential cation channel, subfamily M, member 1 -3.72 0.051
1445450_x_at A530021J07Rik -3.71 0.012
1421234_at Hnf1a, HNF1 homeobox A -3.45 0.044
1448485_at Ggt1, gamma-glutamyltransferase 1 -3.39 0.005
1445194_at Cnksr2, connector enhancer of kinase suppressor of Ras 2 -3.31 0.034
1418545_at Wasf1, WASP family 1 -3.01 0.016
1451548_at Upp2, uridine phosphorylase 2 -2.91 0.049
1434722_at Ampd1, adenosine monophosphate deaminase 1 -2.85 0.004
1436836_x_at Cnn3, calponin 3, acidic -2.79 0.005
1429274_at 2310010M24Rik -2.46 0.001
1455442_at Slc6a19, solute carrier family 6 member 19 -2.34 0.005
1432383_a_at Armc9, armadillo repeat containing 9 -2.29 0.020
1417928_at Pdlim4, PDZ and LIM domain 4 -2.28 0.055
1444801_at 2900041M22Rik -2.27 0.029
1443570_at Cops3, COP9 (constitutive photomorphogenic) homolog, subunit 3 -2.25 0.005
1421895_at Eif2s3x, eukaryotic translation initiation factor 2, subunit 3 -2.25 0.013
1418055_at Neurod4, neurogenic differentiation 4 -2.23 0.020
1453009_at Gene name not assigned for this probe set -2.22 0.014
1429350_at Eid3, EP300 interacting inhibitor of differentiation 3 -2.21 0.039
1420877_at Sept6, septin 6 -2.17 0.001
1438825_at Calm3, Calmodulin 3 -2.16 0.022
1434915_s_at Lrrc19, leucine rich repeat containing 19 -2.12 0.041
1436103_at Rab3ip, RAB3A interacting protein -2.12 0.006
1456751_x_at A530021J07Rik -2.12 0.000
1439254_at Gene name not assigned for this probe set -2.11 0.037
1418003_at 1190002H23Rik -2.11 0.037
1449634_a_at Anks1b, ankyrin repeat and sterile alpha motif domain containing 1B -2.09 0.047
1418990_at Ms4a4d, membrane-spanning 4-domains, subfamily A, member 4D -2.09 0.031
1421182_at Clec1b, C-type lectin domain family 1, member b 3.7 0.038
1424842_a_at Arhgap24, Rho GTPase activating protein 24 3.74 0.014
1418340_at Fcer1g, Fc receptor, IgE, high affinity I, gamma polypeptide 3.76 0.016
1444214_at Tubb1, tubulin, beta 1 3.79 0.044
1452666_a_at Tmcc2, transmembrane and coiled-coil domains 2 3.88 0.033
1457001_at Cenpk, centromere protein K 3.9 0.004
1449340_at Sostdc1, sclerostin domain containing 1 3.91 0.014
1434115_at Cdh13, cadherin 13 3.95 0.054
1434955_at March1, membrane-associated ring finger (C3HC4) 1 4.04 0.000
1439397_at Fmn1, formin 1 4.06 0.026
1448749_at Plek, pleckstrin 4.13 0.010
1426171_x_at Klra7, killer cell lectin-like receptor, subfamily A, member 7 4.14 0.003
1436778_at Cybb, cytochrome b-245, beta polypeptide 4.15 0.012
1448025_at Sirpb1, signal-regulatory protein beta 1 4.2 0.046
1420789_at Klra5, killer cell lectin-like receptor, subfamily A, member 5 4.22 0.018
1441887_x_at EG622976 4.26 0.017
1438553_x_at Gene name not assigned for this probe set 4.28 0.011
1417765_a_at Amy1, amylase 1, salivary 4.29 0.016
1451263_a_at Fabp4, fatty acid binding protein 4 4.32 0.020
1427866_x_at Gene name not assigned for this probe set 4.43 0.037
1454200_at Zeb2, zinc finger E-box binding homeobox 2 4.57 0.022
1420492_s_at Smr3a, submaxillary gland androgen regulated protein 3A 4.79 0.006
1427503_at AI324046 4.85 0.024
1437463_x_at Tgfbi, transforming growth factor, beta induced 5.04 0.005
1419348_at Psp, parotid secretory protein 5.11 0.019
1419874_x_at Zbtb16, zinc finger and BTB domain containing 16 5.46 0.005
1442025_a_at Gene name not assigned for this probe set 5.48 0.002
1449501_a_at Gzmm, granzyme M 6.39 0.013
1425436_x_at Klra3, killer cell lectin-like receptor, subfamily A, member 3 9.92 0.000
1425417_x_at Klra8, killer cell lectin-like receptor, subfamily A, member 8 35.69 0.000
The down-regulated transcripts are shown with "-"BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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probe-sets changing ≥ 2-fold after anti-CD3-stimulation
(compared to the unstimulated state) in the Wt samples
was 4252, and the corresponding number after co-stimu-
lation was 4385 (Figure 2). The overlap between the two
stimulations was 3713 (87% and 85%, respectively; Addi-
tional file 5). However, the differences were significantly
more pronounced in anti-CD3 versus anti-CD3/CD28
activated cells in the Itk-defective group, with only 50% of
the transcripts in the co-stimulated group overlapping
with the CD3-stimulated (p < 10-6) (Additional file 6).
Thus, co-stimulation had much greater effect on Itk-defi-
cient than on Wt cells. We further examined some of the
immune response-related genes previously mentioned.
Ten members of the Klr family were up-regulated in
unstimulated Itk-defective compared to Wt samples
(Table 3), while after stimulation the majority of Klrs were
down-regulated in both Wt and Itk-defective T-cells.
Down-regulation of Klrs were also reported for human
cells from healthy individuals in a recent paper by Wang
et al., where primary human T-cells were analyzed after
anti-CD3/CD28-stimulation [27]. With respect to
cytokine expression, IL-2 and IL-6 were found up-regu-
lated upon anti-CD3-stimulation in both Wt and Itk-defi-
cient samples when compared to the corresponding
unstimulated cells. In contrast, IL-16 and IL-18 were
down-regulated (Additional files 5 and 6). Two cytokines,
whose expression was only altered in Itk-deficient cells
upon anti-CD3-stimulation, were IL-10 (up-regulated)
and IL-33 (down-regulated) (data not shown). IL-33 is a
novel IL-1 family cytokine, IL1F11/IL-33, playing an
important role in eosinophil-mediated inflammation
[28]. Interestingly, Itk-deficient mice have previously
been shown to have reduced lung inflammation, eosi-
nophil infiltration and mucous production after induc-
tion of allergic asthma [29]. No other cytokines were
differentially expressed. In the stimulated Wt samples we
also observed altered expression of several transcription
factors such as Zbtb16 (encoding the transcriptional regu-
lator PLZF), Id2 and Spi-C, while in Itk-defective cells we
found Zbtb16, Spi-C and Id3 to be differentially expressed
upon stimulation.
CD4+ and CD8+ T-cell signatures in Itk-deficiency
As T-cells can be divided into CD4+ and CD8+ subsets, and
as these subsets have very distinct functions and gene reg-
ulations, we examined Itk-deficiency in MACS purified
CD4+ and CD8+ Wt and Itk-deficient T-cells. The Itk-defi-
cient CD4+ and CD8+ T-cells are known from previous
studies to be of a memory-like phenotype, characterized
by the markers CD44 and CD122 [9-11,13]. Since CD122
expression is enhanced by the transcription factors eomes-
odermin and T-box 21 (T-bet), we looked for their expres-
sion in our data. Eomesodermin was previously reported
to be up-regulated in Itk-deficient T-cells [9] and we found
the expression of eomesodermin much higher in the
CD8+ T-cell population compared to CD4+ in unstimu-
lated condition. The same was also seen with T-bet. Taken
together, the observed expression pattern of eomesoder-
min and T-bet is in agreement with previously published
studies and thus validates our microarray data. Moreover,
our analysis also includes new knowledge related to these
transcripts, namely how they respond to activation of T-
cells as well as the effect of CsA (Additional file 7).
Both CD4+ and CD8+ T-cell subsets in Itk-deficient mice
have been shown to differ in phenotype compared to the
Wt mice. In the absence of Itk, a higher percentage of each
subset expresses surface markers, typical for memory phe-
notype cells, such as CD44hi and CD122hi [9,10,13]. We
sought to determine whether this was also reflected by
their transcriptomes. The number of transcripts differen-
tially expressed between unstimulated Itk-/- and Wt in the
CD4+ population was 2050, while in the CD8+ population
the number was higher (n = 6907). The 60 most up- and
down-regulated transcripts from each subset are shown in
Tables 5 and 6. Among those are genes already men-
tioned, e.g. eomesodermin, Klra3 and 8, T-bet and
Granzyme M. In these groups we also found Zbtb16.
Interestingly, Zbtb16 was 12-fold up-regulated in CD4+
cells and 45-fold down-regulated in CD8+ cells, also sug-
gesting a highly efficient separation of the two subsets.
Based on these findings PLZF was selected for further stud-
ies presented elsewhere [30]. The most pronounced
changes were seen in the CD8+ population (Table 6), with
69-fold down-regulation of Clca1, which is a calcium-acti-
vated chloride-channel, of importance in airway epithelial
cells. Two up-regulated transcripts were the PTB-domain
containing MAP-kinase regulator Dok5 (29-fold) and α-
tubulin (30-fold), whose expression in T-cells, to our
knowledge, was not previously reported. After anti-CD3-
Table 2: Groups of genes expressed in the immune response group
Immune response groups Number of genes involved Immune response groups Number of genes involved
Chemokine receptors 5 Interleukins 4
Chemokines 8 Intracellular signaling components 7
Colony stimulating factor receptors 4 Killer cell lectin-like receptors 11
Fc receptors 5 Miscellaneous 24
Granzymes 4 Other surface antigens with CD-
designation
17
Interferon-related genes 3 Toll-like receptors 2
Interleukin receptors 4 Transcription factors 9BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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stimulation we found the number of differentially
expressed transcripts reduced in both subsets, approxi-
mately 30% and 47% fewer probe-sets in CD4+ and CD8+,
respectively. The overlapping probe-sets between the
unstimulated and the anti-CD3-stimulated conditions are
shown in Figure 3. 82% of the transcripts in the CD4+ sub-
set were also found in the CD8+ population in unstimu-
lated cells. The percentage of overlapping transcripts
decreased with stimulation.
The largest number of differentially expressed transcripts
was observed in the unstimulated groups of Itk-deficient
CD4+ and CD8+ T-cell subsets. By subtracting the over-
lapping 1495 probe-sets (Figure 3) from unstimulated Itk-
deficient CD4+ and CD8+ cells, respectively, we character-
ized separate core groups of transcripts for each subset.
The remaining number of probe-sets in the CD4+ popula-
tion was 324 (Additional file 8), while it was more than
10-fold higher in the CD8+ group (Additional file 9).
Interestingly, two members of the Klr family (Klrb1a
(Ly55a) and Klrb1c (NK-1.1)) were present in the
CD4+population, while four other members were found
in the CD8+ subset (Klra4 (Ly49D), Klra19 (Ly49S), Klrc2
(NKG2C) and Klrk1 (NKG2D)). Five Klrs were in com-
mon between unstimulated CD4+ and CD8+ groups, they
were Klra3, a7, a8, a22 and b1b (by comparing 2050 and
6907 in Fig. 3). The differentially expressed NK/innate
cell-related transcripts were not limited to cell surface
markers, since RNA for the cytotoxic protein Granzyme M
was strongly enriched in the Itk-deficient population,
again confirming that NK- and innate cells have overlap-
ping transcriptomes [31].
Itk-deficiency mimics calcineurin inhibition
Tec-family kinases activate PLCγ and are therefore impor-
tant regulators of Ca2+-mobilization and the calcineurin/
NFAT pathway [5,32]. However, Tec-family kinases regu-
late also other signaling pathways. To investigate which of
the Itk-related changes is the consequence of an impaired
calcineurin/NFAT pathway, we compared the expression
profiles of anti-CD3 ± CD28 stimulated Itk-/- CD3+ T-cells
and of CsA-treated Wt T-cells. CsA specifically inhibits cal-
cineurin and by that affects downstream signaling and the
activation of the transcription factors of the NFAT-family.
Based on the dependency of Itk and/or calcineurin, three
groups of genes could be identified: Itk- and calcineurin-
dependent (Itk/CN); Itk-dependent and calcineurin-inde-
pendent (Itk/non-CN) and Itk-independent and cal-
cineurin-dependent (non-Itk/CN).
Table 3: The genes found in Killer cell lectin-like receptor and transcription factor groups from Table 2
Killer cell lectin-like receptors
Probe set Gene title Itk-/- vs Wt
1458642_at killer cell lectin-like receptor family E member 1 (NKG2I) 2.6
1451664_x_at killer cell lectin-like receptor subfamily A, member 12 (Ly49L) 2.13
1422065_at killer cell lectin-like receptor subfamily B member 1B (Ly55B/Ly55D) 3.16
1425005_at killer cell lectin-like receptor subfamily C, member 1 (NKG2A/2B) 2.13
1420790_x_at killer cell lectin-like receptor, subfamily A, member 16 (Ly49P) -2.62
1426127_x_at killer cell lectin-like receptor, subfamily A, member 18 (Ly49R) 2.99
1426140_x_at killer cell lectin-like receptor, subfamily A, member 19 (Ly49S) 2.73
1425436_x_at killer cell lectin-like receptor, subfamily A, member 3 (Ly49C) 9.92
1420789_at killer cell lectin-like receptor, subfamily A, member 5 (Ly49E) 4.22
1426171_x_at killer cell lectin-like receptor, subfamily A, member 7 (Ly49G) 4.14
1425417_x_at killer cell lectin-like receptor, subfamily A, member 8 (Ly49H) 35.69
Transcription factors
Probe set Gene title Itk-/- vs Wt
1416916_at E74-like factor 3 2.97
1457441_at early B-cell factor 1 *
1416301_a_at early B-cell factor 1 *
1435172_at eomesodermin homolog (Xenopus laevis) 2.56
1426001_at eomesodermin homolog (Xenopus laevis) 3.07
1421303_at IKAROS family zinc finger 1 -2.2
1422537_a_at inhibitor of DNA binding 2 2.03
1447640_s_at pre B-cell leukemia transcription factor 3 2.05
1460407_at Spi-B transcription factor (Spi-1/PU.1 related) 2.38
1429427_s_at transcription factor 7-like 2, T-cell specific, HMG-box 2.41
1419874_x_at zinc finger and BTB domain containing 16 5.46
* Early B-cell factor 1 showed variable expression changes for different probe sets
The down-regulated transcripts are shown with "-"BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Table 4: The 60 most up- and down-regulated transcripts in Itk-deficiency after anti-CD3- (1) and anti-CD3/CD28-stimulation (2)
Probe set Gene Symbol, Gene Title Itk-/- vs Wt (1) t-test Itk-/- vs Wt (2) t-test
1457120_at Itk, IL2-inducible T-cell kinase -6.96 0.007 -6.63 0.009
1451191_at Crabp2, cellular retinoic acid binding protein II -5.31 0.013 -2.79 0.054
1449990_at Il2///LOC630222, interleukin 2 -3.89 0.002 -5.17 0.030
1436194_at Prelid2, PRELI domain containing 2 -3.54 0.036 -2.42 0.077
1437935_at 4930486G11Rik, RIKEN cDNA -3.44 0.032 -3.16 0.079
1439995_at Nhedc2, Na+/H+ exchanger domain containing 2 -2.92 0.021 -2.71 0.028
1441971_at Gene name not assigned for this probe set -2.91 0.050 -2.88 0.082
1426243_at Cth, cystathionase -2.9 0.000 -2.8 0.072
1438380_at Ddx47, DEAD box polypeptide 47 -2.69 0.002 2.03 0.300
1450566_at Il3, interleukin 3 -2.68 0.031 -2.81 0.005
1420843_at Ptprf, protein tyrosine phosphatase, receptor type, -2.49 0.027 -2.07 0.222
1448788_at Cd200, Cd200 antigen -2.47 0.014 -2.43 0.011
1427049_s_at Smo, smoothened homolog (Drosophila) -2.46 0.000 -2.45 0.015
1422070_at Adh4, alcohol dehydrogenase 4 (class II) -2.33 0.015 -2.26 0.157
1456226_x_at Ddr1, discoidin domain receptor family, member 1 -2.29 0.014 -2.91 0.038
1419136_at Akr1c18, aldo-keto reductase family 1, member C18 -2.09 0.052 2.41 0.008
1433571_at Serinc5, serine incorporator 5 -2 0.011 -2.05 0.125
1425832_a_at Cxcr6, chemokine (C-X-C motif) receptor 6 5.34 0.000 3.27 0.085
1437463_x_at Tgfbi, transforming growth factor, beta induced 5.36 0.045 2.4 0.012
1421802_at Ear1, eosinophil-associated, ribonuclease A family, member 1 5.38 0.017 2.8 0.000
1448620_at Fcgr3, Fc receptor, IgG, low affinity III 5.57 0.036 3.72 0.004
1438855_x_at Tnfaip2, tumor necrosis factor, alpha-induced protein 2 5.6 0.0034 3.12 0.000
1450009_at Ltf, lactotransferrin 5.68 0.080 2.03 0.034
1416514_a_at Fscn1, fascin homolog 1 5.7 0.000 3.69 0.096
1451948_at Gm1409, gene model 1409 5.81 0.002 3.45 0.136
1451675_a_at Alas2, aminolevulinic acid synthase 2, erythroid 5.84 0.003 2.92 0.096
1420330_at Clec4e, C-type lectin domain family 4, member e 5.89 0.014 3.15 0.091
1420699_at Clec7a, C-type lectin domain family 7, member a 5.98 0.014 4.05 0.004
1427747_a_at Lcn2, lipocalin 2 5.98 0.056 2.23 0.011
1427503_at AI324046, expressed sequence AI324046 6.33 0.005 3.48 0.055
1419082_at Serpinb2, serine (or cysteine) peptidase inhibitor, clade B, member 2 6.34 0.001 2.51 0.125
1419627_s_at Clec4n, C-type lectin domain family 4, member n 6.36 0.021 2.6 0.0129
1448213_at Anxa1, annexin A1 6.43 0.069 3.07 0.029
1419874_x_at Zbtb16, zinc finger and BTB domain containing 16 6.62 0.032 5.3 0.001
1417898_a_at Gzma, granzyme A 6.71 0.009 5.59 0.001
1419598_at Ms4a6d, membrane-spanning 4-domains, subfamily A, member 6D 6.73 0.005 3.27 0.083
1429889_at Faim3, Fas apoptotic inhibitory molecule 3 6.73 0.047 3.01 0.041
1415904_at Lpl, lipoprotein lipase 6.76 0.054 4.1 0.026
1449254_at Spp1, secreted phosphoprotein 1 6.8 0.028 3.79 0.020
1427910_at Cst6, cystatin E/M 7.1 0.023 4.17 7.43E-06
1438553_x_at Gene name not assigned for this probe set 7.11 0.011 4.63 0.055
1434150_a_at Mettl7a///Ubie, methyltransferase like 7A 7.14 0.000 4.04 0.185
1442025_a_at AI467657, expressed sequence AI467657 7.48 0.041 6.52 0.000
1436778_at Cybb, cytochrome b-245, beta polypeptide 7.77 0.077 4.03 0.003
1439426_x_at Lyz, lysozyme 7.78 0.006 2.98 0.011
1449846_at Ear2///Ear3, eosinophil-associated, ribonuclease A family, member 2 8.62 0.008 3.54 0.031
1434194_at Mtap2, microtubule-associated protein 2 8.73 0.035 5.78 0.000
1427866_x_at Beta globin 9.29 0.001 5.44 0.074
1450912_at Ms4a1, membrane-spanning 4-domains, subfamily A, member 1 9.4 0.087 4.31 0.036
1422873_at Prg2, proteoglycan 2, bone marrow 9.81 0.028 4.19 0.026
1419764_at Chi3l3, chitinase 3-like 3 10.51 0.070 4.1 0.004
1422411_s_at Ear1///Ear12///Ear2///Ear3, eosinophil-associated, ribonuclease A family, 
member 1
10.54 0.010 4.61 0.000
1418722_at Ngp, neutrophilic granule protein 11.39 0.031 3.74 0.006
1450989_at LOC100047300///Tdgf1, teratocarcinoma-derived growth factor 11.64 0.009 2.89 0.076
1419394_s_at S100a8, S100 calcium binding protein A8 12.08 0.071 4.6 0.034
1425436_x_at Klra3, killer cell lectin-like receptor, subfamily A, member 3 12.34 0.002 14.75 0.000
1415897_a_at Mgst1, microsomal glutathione S-transferase 1 12.62 0.082 3.77 0.006
1448756_at S100a9, S100 calcium binding protein A9 12.97 0.077 5.15 0.010BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Altogether, after anti-CD3-stimulation 4613 probe-sets
were differentially expressed in CsA-treated cells com-
pared to untreated, and after co-stimulation the number
was reduced by 15% to 3936. The gene numbers observed
in Itk-deficient compared to Wt cells were 804 and 409
after anti-CD3- and anti-CD3/CD28-stimulation, respec-
tively (Figure 1a). About 60% of the probe-sets that were
changed ≥ 2-fold in Itk-/- compared to Wt after anti-CD3-
stimulation were also found in the CsA-treated samples
(Figure 4, Itk/CN anti-CD3, showing the 10 most highly-
regulated transcripts). In co-stimulated cells 45% of the
probe-sets were the same (Figure 4, Itk/CN anti-CD3/
CD28). When comparing the Itk-dependent probe-sets
being calcineurin-dependent in both stimulations the
overlap was 113 (Additional file 10). As expected, IL-2
was found in that group, confirming the biological rele-
vance of our data, since IL-2 is known to be both Itk- and
calcineurin-dependent [16,33]. Among other genes found
in this group were Zbtb16  (up-regulated) and Crabp2
(down-regulated). Interestingly, the transcript for chem-
okine (C-motif) ligand 1 (Xcl1) was down-regulated in
the CsA-treated cells while it showed increased expression
in Itk-deficient samples. Furthermore, cytotoxic T lym-
phocyte-associated protein 2 alpha and beta (Ctla2a and
Ctla2b) were up-regulated. Interestingly, their altered
expression was more pronounced in the CsA-treated (>3
times higher) than in the Itk-deficient samples. Two
granzyme-encoding genes, Gzma  and  Gzmk, were also
found among those that were Itk- and calcineurin-
dependent.
The fractions of Itk/non-CN genes (322 vs 225- for anti-
CD3- and anti-CD3/CD28-stimulated T-cells, respec-
tively) shared 95 probe-sets, corresponding to 89 tran-
scripts (Additional file 11). Among them were three up-
regulated members of the Klrs; Klra5, Klra8 and Klre1.
After co-stimulation, a much smaller number of probe-
sets were Itk-dependent compared to anti-CD3-stimula-
tion only (p < 10-6). The transcripts being calcineurin-
dependent but Itk-independent (non-Itk/CN group) were
4131 and 3752 in anti-CD3- and co-stimulated cells,
respectively. It is interesting to note that CsA-treatment,
but not Itk-deficiency (the non-Itk/CN anti-CD3 group),
results in severely reduced transcript levels for IFNγ. Previ-
ous studies show that an immediate IFNγ release is a hall-
mark of the innate CD8-population [9,10].
NFAT-binding genes that are Itk- and calcineurin- 
dependent
The comparison of Itk-deficient and CsA-treated Wt T-
cells revealed 482 up- or down-regulated transcripts upon
anti-CD3-stimulation. In order to identify putative NFAT-
binding sites (GGAAA), we selected 24 genes for bioinfor-
matic analyses. The genes were chosen as being highly reg-
ulated in the CsA or Itk-/- comparisons after anti-CD3-
stimulation. 19/24 of these genes were also significantly
regulated after co-stimulation with anti-CD3/CD28. 15/
24 genes had putative NFAT-sites in the 500 bp region
upstream of the transcriptional start site (Additional file
12). We identified 1 to 2 binding sites in 4 of those genes:
IL7R, Bub1, Ctla2a and Ctla2b, as well as upstream of the
translation initiation of Schlafen1 (Slfn1) gene (Figure 5a).
To test whether NFAT binds to the promoter region of the
genes  in vivo, chromatin-immunoprecipitation experi-
ments were performed. As a positive control, we used the
IL-2 promoter region known to contain functional NFAT-
sites bound by NFATc1 [34,35]. ChIP assays demon-
strated NFATc1 binding to the IL-2 promoter region as
expected and revealed anti-CD3 induced binding of
NFATc1 to the selected regions of the five genes. They were
also shown to be bona fide calcineurin-regulated genes
owing to that the induced binding was reversed by CsA-
treatment (Fig. 5b). A heat-map presenting the signal
intensities of the above mentioned genes is shown in Fig-
ure 5c.
Transcripts regulated by Tec-family kinases
Itk is crucial for T-cell development and activation. Simi-
larly, Btk is essential for proper differentiation and activa-
tion of B-cells [36,37]. In a previous study, we investigated
the genes modulated by Btk [24]. There was a pronounced
overlap 18/38 (47%) between differentially expressed
genes from the Itk-defective T-cells (900-list) and the pre-
viously published list of Btk-deficient genes from splenic
B-cells as analyzed by the U74Av2 chip with approxi-
mately 12 000 genes [24]. The overlapping transcripts are
shown in Table 7. Sixteen of the 18 genes were similarly
regulated, which shows a highly significant co-variation
(p = 0.01). Among these genes were those for transcrip-
tion factors (Id2, Ikaros and Spi-C), cell membrane span-
ning (Csf1r, Mrc1 and Vcam1) and secreted proteins
(Aif1, Igf1 and Tgfbi).
Discussion
For any analysis of individuals with defective genes there
are important considerations related to the choice of accu-
rate controls and the adequate interpretation of the data.
This is nicely exemplified in Itk-deficiency. Thus, when
mice with Itk-deficiency are immunized and generate
impaired responses it is unclear to what extent the impair-
ment is caused by the reduced numbers of mature T-lym-
phocytes as compared to the increased innate populations
1426171_x_at Klra7, killer cell lectin-like receptor, subfamily A, member 7 14.08 0.027 14.02 0.015
1425417_x_at Klra8, killer cell lectin-like receptor, subfamily A, member 8 21.07 0.026 17.99 0.000
The down-regulated transcripts are shown with "-"
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The number of differentially expressed probe-sets in Itk-deficiency Figure 1
The number of differentially expressed probe-sets in Itk-deficiency. a. Venn diagram showing overlapping probe-sets 
in CD3+ Itk-defective T-cells, unstimulated (upper), anti-CD3- (left) and anti-CD3/CD28-stimulated (right). All the compari-
sons were made against Wt and with the criterion ≥ 2-fold. b. Quantitative RT-PCR confirms up-regulated expression of 
Klra3, Klra7 and Klrg1 in Itk-deficiency. The bar charts show relative amount of Klr mRNA compared to unstimulated Wt 
CD3+ T-cells (Wt C).BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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versus that the mature as well as the innate populations
are deficient because they lack Itk. The net outcome is the
sum of these alterations. The same is true in microarray
experiments or when phenotypic markers are assayed by
other means. In the likely event that the innate popula-
tions themselves are further altered owing to lack of Itk,
the corresponding population may not even exist in the
Wt. The same principle is true for any mutant gene, and it
is important to be aware of this fact when interpreting
data, including expression profiling, related to such
defects. In this report we describe the phenotypic changes
in Itk-deficiency and make comparisons to CsA-treat-
ment. Owing to the very large number of genes with
altered expression, we here provide an overview of the
observed changes. We pinpoint some of the interesting
findings obtained from this dataset. However, the original
gene profiling data, available to any investigators at GEO,
could be analyzed in different ways, depending on the
biological question to be answered.
T-cells deficient for the Tec-family kinase Itk have severe
impairment during T-cell activation. Furthermore, Itk has
also been shown to be involved in signaling pathways that
regulate the development decisions of conventional ver-
sus innate-like T-cell development [9-13], since CD8+ T-
cells and a certain fraction of CD4+ T-cells have an innate-
like T-cell phenotype. Collectively, these studies revealed
that Itk has a crucial and important function in T-cells. In
this study we performed an Affymetrix microarray expres-
sion analysis to investigate how Itk-deficiency affects the
expression profile in T-cells. The effect of Itk-deficiency
was investigated in CD3+ T-cells, as well as in the CD4+
and CD8+ T-cell subsets. These signatures for the first time
reveal the transcriptome of Itk-deficiency.
The most pronounced changes were observed in resting
Itk-deficient compared to Wt CD3+ T-cells. This is in agree-
ment with the previous findings that more genes are
expressed in untreated cells as compared to stimulated T-
lymphocytes [38-40]. Thus, after anti-CD3/CD28-stimu-
lation the number of differentially expressed transcripts
was dramatically decreased in Itk-defective (down by
approximately 50%) compared to Wt cells. This suggests
that the CD28 co-stimulatory pathway is less dependent
of Itk. It was previously shown that Itk was a negative reg-
ulator of CD28-signaling in CD4+ T-cells [41]. However,
sorted naïve CD4+ T-cells from Itk-deficient mice had nor-
mal CD28 co-stimulatory responses when compared to
Wt cells [42], showing that CD28-signaling is not depend-
ent on Itk in these cells. Our result confirms that Itk is not
essential for CD28-signaling and suggests that a great deal
of the TCR signaling defects in Itk-/- T-cells is rescued by
CD28 co-stimulation in vitro. However, expression of
genes that is essential for T-cell proliferation like Il2
remain Itk-dependent after co-stimulation.
It was satisfying to observe the most pronounced tran-
scriptional changes in CD8+ cells, since Itk-deficiency is
known to predominantly affect this subpopulation [9-
11]. The overlap between CD4+ and CD8+ subsets was
highest in untreated cells indicating an innate-like pattern
also of the CD4+ population. Moreover, a recent paper
showed that CD4+ T-cells in Itk-deficient mice have a
memory phenotype with expression of typical surface
markers such as CD62Llow and CD44high [13]. When look-
ing at the specific transcripts for each T-cell subset we
found differences in expression of Klrs, two members in
CD4+ and four in CD8+. Klrb1a (Ly55a) and Klrb1c (NK-
1.1) were found in CD4+ T-cells. To our knowledge, only
NK-1.1 was previously reported for Itk-deficient CD4+ T-
cells [13]. Klrc2 (NKG2C) and Klrk1 (NKG2D) were pre-
viously reported in CD8+ T-cells [11]. In addition, we
found Klra4 (Ly49D) and Klra19 (Ly49S), not previously
described in this context. In unstimulated Itk-/- CD3+ T-
cells eleven Klr members were found (shown in Table 3).
Klra3, a7, a8 and b1b were shown to be common to the
CD4+ and CD8+ subsets. Interestingly, we found Klra3 and
Klra7 to also be calcineurin-dependent, while Klra8 was
only Itk-dependent. Of note is also that a cytosolic protein
known to characterize NK-cells, granzyme M, was present
in the data. It has recently been shown to be expressed in
NK-cells and cytotoxic T-cells with innate immune func-
tion [31]. Here, we show for the first time up-regulation of
The amount of differentially expressed probe-sets in Wt and  Itk-defective CD3+ T-cells following stimulation Figure 2
The amount of differentially expressed probe-sets in 
Wt and Itk-defective CD3+ T-cells following stimula-
tion. The upper panel represents the Wt T-cells and the 
lower the Itk-defective T-cells. The left panel symbolizes the 
anti-CD3-stimulation and the right panel the anti-CD3/
CD28-stimulation. All the stimulations were compared to 
the untreated condition. The arrows denote the number of 
overlapping probe-sets.
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Table 5: The 60 most up- and down-regulated transcripts in Itk-defective CD4+ T-cells (unstimulated cells)
Probe set Gene Symbol, Gene Title Itk-/- vs Wt t-test
1436386_x_at OTTMUSG00000010671 -7.51 0.012
1444708_at Tmem29, transmembrane protein 29 -5 0.014
1434418_at Lass6, LAG1 homolog, ceramide synthase 6 -4.93 0.001
1438354_x_at Cnn3, Calponin 3, acidic -4.81 0.030
1430988_at 2810407C02Rik -3.84 0.028
1430827_a_at Ptk2, PTK2 protein tyrosine kinase 2 -3.68 0.002
1458977_at A530021J07Rik -3.36 0.006
1439778_at Cables1, Cdk5 and Abl enzyme substrate 1 -3.26 0.018
1427675_at V1ra2, vomeronasal 1 receptor, A2 -3.22 0.041
1448338_at Pgcp, plasma glutamate carboxypeptidase -3.16 0.001
1458945_at AU015148 -3.16 0.038
1421507_at Olfr78, olfactory receptor 78 -3.07 0.021
1457120_at Itk, IL2-inducible T-cell kinase -2.96 0.002
1456178_at Bambi-ps1, BMP and activin membrane-bound inhibitor, pseudogene (Xenopus laevis) -2.94 0.000
1455907_x_at Phox2b, paired-like homeobox 2b -2.88 0.050
1452474_a_at Art3, ADP-ribosyltransferase 3 -2.86 0.026
1459508_at C85600 -2.79 0.007
1440761_at 4833422C13Rik -2.77 0.052
1446412_at Gene name not assigned for this probe set -2.71 0.012
1441221_at Gene name not assigned for this probe set -2.7 0.019
1427632_x_at Cd55, CD55 antigen -2.65 0.042
1439181_at BC043301 -2.63 0.032
1434473_at Slc16a5, solute carrier family 16 (monocarboxylic acid transporters), member 5 -2.59 0.001
1448002_x_at 2610001J05Rik -2.57 0.018
1455425_at BB001228 -2.57 0.016
1419620_at Pttg1, pituitary tumor-transforming 1 -2.53 0.000
1453009_at Gene name not assigned for this probe set -2.39 0.000
1455740_at Hnrnpa1, heterogeneous nuclear ribonucleoprotein A1 -2.31 0.048
1429413_at Cpm, carboxypeptidase M -2.28 0.003
1416441_at Pgcp, plasma glutamate carboxypeptidase 3.12 0.005
1425216_at Ffar2, free fatty acid receptor 2 3.13 0.036
1448471_a_at Ctla2a, cytotoxic T lymphocyte-associated protein 2 alpha 3.13 0.006
1450334_at Il21, interleukin 21 3.13 0.013
1423091_a_at Gpm6b, glycoprotein m6b 3.21 0.032
1435339_at Kctd15, potassium channel tetramerisation domain containing 15 3.24 0.044
1428197_at Tspan9, tetraspanin 9 3.37 0.001
1449036_at Rnf128, ring finger protein 128 3.44 0.002
1449361_at Tbx21, T-box 21 3.5 0.012
1447839_x_at Adm, adrenomedullin 3.62 0.031
1418318_at Rnf128, ring finger protein 128 3.77 0.021
1419647_a_at Ier3, immediate early response 3 3.78 0.005
1448961_at Plscr2, phospholipid scramblase 2 4.06 0.012
1449280_at Esm1, endothelial cell-specific molecule 1 4.15 0.013
1427445_a_at Ttn, titin 4.32 0.006
1425471_x_at Gene name not assigned for this probe set 4.33 0.050
1438553_x_at Gene name not assigned for this probe set 4.35 0.019
1423231_at Nrgn, neurogranin 4.66 0.002
1416846_a_at Pdzrn3, PDZ domain containing RING finger 3 4.69 0.002
1430946_at 2600014E21Rik 4.82 0.031
1426001_at Eomes, eomesodermin homolog (Xenopus laevis) 5.43 0.024
1422280_at Gzmk, granzyme K 5.6 0.002
1427608_a_at Tcrg-V1, T-cell receptor gamma, variable 1 5.62 0.044
1434194_at Mtap2, microtubule-associated protein 2 5.71 0.040
1434115_at Cdh13, cadherin 13 6.15 0.047
1455435_s_at Chdh, choline dehydrogenase 6.54 0.041
1449864_at Il4, interleukin 4 6.77 0.031
1424011_at Aqp9, aquaporin 9 7.23 0.011
1420678_a_at Il17rb, interleukin 17 receptor B 9.84 0.029
1442025_a_at Gene name not assigned for this probe set 11.69 0.008
1419874_x_at Zbtb16, zinc finger and BTB domain containing 16 12.07 0.009
The down-regulated transcripts are shown with "-"BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Table 6: The 60 most up- and down-regulated transcripts in Itk-defective CD8+ T-cells (unstimulated cells)
Probe set Gene Symbol, Gene Title Itk-/- vs Wt
1417852_x_at Clca1, chloride channel calcium activated 1 -68.71
1419874_x_at Zbtb16, zinc finger and BTB domain containing 16 -45.13
1436759_x_at Cnn3, calponin 3, acidic -39.91
1454869_at Wdr40b, WD repeat domain 40B -34.02
1427054_s_at Abi3bp, ABI gene family, member 3 (NESH) binding protein -31.51
1437992_x_at Gja1, gap junction protein, alpha 1 -25.36
1416203_at Aqp1, aquaporin 1 -24.68
1437279_x_at Sdc1, syndecan 1 -24.33
1448182_a_at Cd24a, CD24a antigen -21.41
1456956_at Ikzf2, IKAROS family zinc finger 2 -19.8
1442025_a_at Gene name not assigned for this probe set -19.78
1439422_a_at C1qdc2, C1q domain containing 2 -19.69
1454086_a_at Lmo2, LIM domain only 2 -18.62
1416330_at Cd81, CD81 antigen -17.08
1451867_x_at Arhgap6, Rho GTPase activating protein 6 -17.08
1456060_at Maf, avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog -16.84
1419014_at Rhag, Rhesus blood group-associated A glycoprotein -16.79
1416193_at Car1, carbonic anhydrase 1 -16.49
1450744_at Ell2, elongation factor RNA polymerase II 2 -14.83
1456147_at St8sia6, ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 -14.78
1456475_s_at Prkar2b, protein kinase, cAMP dependent regulatory, type II beta -14.57
1460431_at Gcnt1, glucosaminyl (N-acetyl) transferase 1, core 2 -14.03
1437171_x_at Gsn, gelsolin -13.64
1417777_at Ltb4dh, leukotriene B4 12-hydroxydehydrogenase -13.54
1437935_at 4930486G11Rik -13.51
1434499_a_at Ldhb, lactate dehydrogenase B -13.44
1450333_a_at Gata2, GATA binding protein 2 -13.33
1423569_at Gatm, glycine amidinotransferase (L-arginine:glycine amidinotransferase) -12.94
1435884_at Itsn1, intersectin 1 (SH3 domain protein 1A) -12.72
1425145_at Il1rl1, interleukin 1 receptor-like 1 -12.6
1449313_at Klk1b5, kallikrein 1-related peptidase b5 13.38
1454106_a_at Cxxc1, CXXC finger 1 (PHD domain) 13.41
1442639_at Gene name not assigned for this probe set 13.76
1443006_at Gene name not assigned for this probe set 13.93
1433449_at Snx32, sorting nexin 32 14.78
1423603_at Zfpm1, zinc finger protein, multitype 1 14.98
1441770_at Ppat, phosphoribosyl pyrophosphate amidotransferase 15.29
1420343_at Gzmd, granzyme D 15.42
1445596_at Gene name not assigned for this probe set 15.54
1452985_at Uaca, uveal autoantigen with coiled-coil domains and ankyrin repeats 16.55
1420233_at Gene name not assigned for this probe set 16.79
1423020_at Gene name not assigned for this probe set 17.39
1454481_at Mif, macrophage migration inhibitory factor 17.64
1427426_at Kcnq5, potassium voltage-gated channel, subfamily Q, member 5 18.06
1424698_s_at Gca, grancalcin 18.46
1447574_s_at Slc32a1, Solute carrier family 32 (GABA vesicular transporter), member 1 18.73
1431854_a_at 4930452B06Rik 18.94
1460267_at Dmrt3, doublesex and mab-3 related transcription factor 3 19.76
1417197_at Wwc2, WW, C2 and coiled-coil domain containing 2 20.76
1442788_at Afap1, actin filament associated protein 1 20.91
1447292_at Actr1b, ARP1 actin-related protein 1 homolog B (yeast) 21.96
1431878_at Grhl2, grainyhead-like 2 (Drosophila) 22.18
1449501_a_at Gzmm, granzyme M (lymphocyte met-ase 1) 23.58
1436500_at Rps24, Ribosomal protein S24 25.96
1425436_x_at Klra3, killer cell lectin-like receptor, subfamily A, member 3 26.39
1456130_at LOC553091 27.36
1454240_at Nfe2l3, nuclear factor, erythroid derived 2, like 3 29.25
1422641_at Dok5, docking protein 5 29.31
1417375_at Tuba4a, tubulin, alpha 4A 30.36
1425417_x_at Klra8, killer cell lectin-like receptor, subfamily A, member 8 131.81
The down-regulated transcripts are shown with "-"BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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this transcript in CD8+ Itk-defective T-cells. As expected,
more differentially expressed genes were revealed follow-
ing separation into the CD4+ and CD8+ subsets. In a
mixed population changes that affect both subsets in a
similar way are preferentially detected.
Itk-deficiency partially mimicked CsA-treatment, since
there was a large overlap of affected transcripts. However,
we observed that CsA had a much greater effect on tran-
scriptional regulation compared to loss of Itk, especially
after co-stimulation. Approximately 4000 genes were
affected by CsA following either anti-CD3- or anti-CD3/
CD28-stimulation, while the corresponding numbers for
those also affected by Itk was 482 and 184, respectively.
113 probe-sets were shared between Itk-defective and
CsA-treated T-cells independent of stimulation. Among
them we found Zbtb16, encoding the transcriptional regu-
lator PLZF, and Xcl1, which is also called lymphotactin or
ATAC, a chemokine mainly produced by activated CD8+
T-cells [43,44]. Also, Crabp2 was found in this comparison
showing its calcineurin-dependency. Crabp2 is involved in
regulating access of retinoic acid to its nuclear receptors, is
developmentally regulated [45], and has been implicated
in various forms of tumors. In addition, our analysis
revealed that some of the Itk-induced changes are inde-
pendent of the Ca2+/calcineurin pathway (322 and 225
transcripts after anti-CD3- and anti-CD3/CD28-stimula-
tion, respectively). In this study we did not treat Itk-defi-
cient cells with CsA. Such experiments could give further
insights into the calcineurin-dependent regulation.
One interesting example of how different members of a
gene family are differentially affected by Itk-deficiency
and CsA-treatment is provided by the Granzyme family.
Granzymes are serine proteases expressed in cytotoxic
lymphocytes [46]. Interestingly, Granzymes A and K were
both Itk- and calcineurin-dependent, while granzymes E
and M were found to be Itk-dependent and calcineurin-
independent after anti-CD3-stimulation. Both granzymes
A and K induce caspase-independent cell death. Not much
is known about granzyme E, while granzyme M is known
to induce cell death in a caspase- and mitochondria-inde-
pendent way [46]. Granzyme B was only affected in CsA-
treated samples and has been shown to be involved in the
induction of caspase-dependent apoptosis. Collectively,
this demonstrates that expression of granzymes is differ-
entially controlled.
Overlapping probe-sets in unstimulated and anti-CD3-stimulated Itk-deficient CD4+ (left) and CD8+ (right) T-cell populations Figure 3
Overlapping probe-sets in unstimulated and anti-CD3-stimulated Itk-deficient CD4+ (left) and CD8+ (right) T-
cell populations. Each circle is a comparison between Itk-defective and Wt samples. All the comparisons were made with the 
criterion ≥ 2-fold.BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Anti-CD3- and anti-CD3/CD28-stimulations leading to Itk- and calcineurin-dependent and -independent transcriptional signa- tures Figure 4
Anti-CD3- and anti-CD3/CD28-stimulations leading to Itk- and calcineurin-dependent and -independent tran-
scriptional signatures. Three different groups of genes exist in each stimulation condition. The groups are Itk- and cal-
cineurin-dependent (Itk/CN), Itk-dependent and calcineurin-independent (Itk/non-CN) and Itk-independent and calcineurin-
dependent (non-Itk/CN). 113 probe-sets are overlapping between Itk/CN groups in the two stimulations. In each group the 10 
most highly regulated transcripts are presented. All the chosen genes passed the t-test criterion of p < 0.05. The down-regu-
lated transcripts are shown with "-". The transcripts in the two Itk/CN groups passed the criterion in at least one of the two 
comparisons. Genes previously known to be calcineurin-regulated are grey-shaded [16]. Arrows denoting signal transduction 
from CD28 have been omitted for clarity.BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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The comparison of Itk-deficiency and CSA-treated CD3+ T-
cells led also to the identification of novel NFAT target
genes. The combination of a bioinformatics approach and
chromatin-immunoprecipitation assays revealed that
IL7R, Schlafen1, Bub1, Ctla2a and Ctla2b are novel Itk- and
calcineurin-dependent genes with seemingly functional
NFAT-binding sites. However, they can be regulated in dif-
ferent ways, e.g. Ctla2a and Ctla2b, IL7R and Slfn1 were
negatively regulated, while IL-2 and Bub1 were positively
regulated by CN-dependent pathways. The same regula-
tion pattern was observed in unstimulated Itk-deficient
samples, but after anti-CD3-stimulation IL7R and Slfn1
became positively regulated by Itk (Fig. 5c). Members of
the Schlafen (Slfn) protein family have been implicated in
the regulation of cell growth and T-cell development. Fur-
thermore, similar to the Il2 gene [47], AP-1 and NF-κB are
reported to regulate Slfn2 expression [48]. Bub1 (budding
uninhibited by benomyl) is a serine/threonine kinase that
has a function in the mitotic spindle checkpoint and is
mutated in certain types of human cancer [49]. Ctla2a and
Ctla2b are cysteine proteinase inhibitors expressed in acti-
vated T-cells and mast cells [50]. Both naïve and memory
T-cells have high levels of IL7R, and IL7 is required for
their homeostasis [51]. Furthermore, recently it was
shown that Wt and Itk-deficient CD4+ T-cells express sim-
ilar levels of IL7R (CD127) [13]. Certain genes in the Itk/
CN group did not have bona fide NFAT-sites as determined
by our bioinformatic approach. This could be due to that
the current data base algorithms are not good enough to
predict the putative sites or that the chromosomal
stretches harboring NFAT-sites are located outside the 500
bp region that we choose to study. Future studies will aim
to reveal a possible link between the altered expression of
these genes and the phenotype of Itk-deficiency.
Finally, a comparative analysis of Itk-deficient T-cells and
Btk-deficient B-cells revealed a significant overlap of tran-
scripts, indicating that there is a common Tec family gene
expression profile in lymphocytes. The fact that 16/18
genes had a similar fold-induction in T- and B-cells (p <
0.05) suggests common regulation of these genes by Itk
and Btk. Conversely, the observation that two transcripts
(Col14a1 and Ccr1) were differentially expressed may
simply reflect that B- and T-cells represent different line-
ages, each characterized by unique features of their tran-
scriptomes. Of the six most up-regulated genes in Btk-
deficiency [24] all of them were >2-fold changed in cells
lacking Itk, eight of which were also significantly altered
in Itk-deficient T-cells (with p-values ranging from <0.05
to <3 × 10-5). Tgfbi, which was up-regulated in Btk-/- and
confirmed as highly increased in Itk-/- (p < 3 × 10-5) sam-
ples, encodes an extracellular protein that mediates cell
adhesion to collagen, laminin and fibronectin via its
interaction with integrins [52]. Since these 16 genes are
common to both Btk- and Itk-dependent transcriptomes
NFAT-binding genes being Itk- and calcineurin-dependent Figure 5
NFAT-binding genes being Itk- and calcineurin-
dependent. a. Promoter regions with NFAT-binding sites in 
IL2, IL7R, Bub1, Slfn1 (Schlafen1), Ctla2a and Ctla2b genes are 
shown with the binding site(s) represented by black boxes. 
This identification was done by bioinformatic analyses of the 
500 bp region upstream of each gene's transcriptional start 
site. This approach identified 1–2 NFAT binding sites within 
the promoter regions of these genes as well as upstream of 
the translation initiation of Slfn1 gene. The numbers below 
each box represent the position of the binding site in correla-
tion to the transcription start. The arrows indicate forward 
and reverse primers. b. NFATc1-binding in IL2, IL7R, Bub1, 
Slfn1, Ctla2a and Ctla2b genes. CD3+ T-cells were isolated 
from Wt thymus (thy) and spleen (spl) as described in exper-
imental procedures. The PCR pictures were analyzed with 
Fluoro-S gel documentation equipment (BioRad Laboratories, 
CA) with a CCD camera, and further evaluated using the 
Quantity One software. Input; DNA before IP, NTC; no tem-
plate control. c. Signal intensities of the six genes in Wt 
unstimulated, Wt anti-CD3-stimulated, Wt anti-CD3-stimu-
lated + CsA-treated, Itk-defective unstimulated and Itk-defec-
tive anti-CD3- stimulated samples. The figure was made in 
dChip [21]. The color scale in the lower part of the picture 
corresponds to the mean expression of a gene. The red color 
represents expression level above mean expression of a gene 
across all samples, the white color is mean expression and 
the blue color represents expression lower than the mean.BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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it seems likely that the corresponding promoters could be
activated through signaling components controlled by
either pathway. Future identification of regulatory ele-
ments targeted by common factors could reveal the under-
lying mechanism.
Conclusion
This report is the first to define the transcriptional signa-
ture of cells from Itk-/- mice. The transcriptome of Itk-defi-
cient cells revealed that there is a large overlap with
regular CD4+ and CD8+ cells. Future studies analyzing dif-
ferent stages of innate, memory-like cells from Wt mice
will aid in unraveling to what extent the innate popula-
tion of Itk-deficiency also shows unique features, which
differ from normal mice.
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Additional File 1
Antibodies used in the isolation of CD3+ T-cells. Antibodies used in the 
isolation of CD3+ T-cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S1.doc]
Additional File 2
Primer sequences and PCR conditions used in the chromatin-immu-
noprecipitation assay. PCR conditions and primer sequences for the 
genes IL2, IL7R, Schlafen1, Bub1, Ctla2a and Ctla2b used in the chro-
matin-immunoprecipitation experiment. F, forward primer; R, reverse 
primer and T (a), annealing temperature.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S2.doc]
Table 7: Overlapping transcripts between Btk-/- B-cells and Itk-/- T-cells
U74Av2 MOE 430 2.0 Gene Symbol, Gene Title Fold change Btk-/-/Itk-/-
102330_at 1418204_s_at Aif1, allograft inflammatory factor 1 7.47/2.28
95546_g_at 1419519_at Igf1, insulin-like growth factor 1 6.5/2.46
103226_at 1450430_at Mrc1, mannose receptor, C type 1 5.42/6.06
95597_at 1423414_at Ptgs1, prostaglandin-endoperoxide synthase 1 4.68/2.43 **
95597_at 1436448_a_at Ptgs1, prostaglandin-endoperoxide synthase 1 4.68/2.19 **
96020_at 1417063_at C1qb, complement component 1, q subcomponent, beta polypeptide 4.57/6.6 ***
96020_at 1434366_x_at C1qb, complement component 1, q subcomponent, beta polypeptide 4.57/5.87 ***
96020_at 1437726_x_at C1qb, complement component 1, q subcomponent, beta polypeptide 4.57/4.46 ***
104354_at 1419873_s_at Csf1r, colony stimulating factor 1 receptor 4.4/3.96 **
104354_at 1423593_a_at Csf1r, colony stimulating factor 1 receptor 4.4/2.95 **
103736_at 1448005_at Sash1, SAM and SH3 domain containing 1 3.97/6.79
103454_at 1418555_x_at Spic, Spi-C transcription factor (Spi-1/PU.1 related) 3.93/3.75 *
103454_at 1449134_s_at Spic, Spi-C transcription factor (Spi-1/PU.1 related) 3.93/8.5 *
92877_at 1415871_at Tgfbi, transforming growth factor, beta induced 3.9/3.46 ***
92877_at 1437463_x_at Tgfbi, transforming growth factor, beta induced 3.9/5.04 ***
92877_at 1448123_s_at Tgfbi, transforming growth factor, beta induced 3.9/4.52 ***
92877_at 1456250_x_at Tgfbi, transforming growth factor, beta induced 3.9/4.6 ***
92223_at 1449401_at C1qc, complement component 1, q subcomponent, C chain 3.73/5.47
92558_at 1448162_at Vcam1, vascular cell adhesion molecule 1 3.63/5.62
102065_at 1418243_at Fcna, ficolin A 3.6/5.27
103070_at 1416985_at Sirpa, signal-regulatory protein alpha 3.42/3.58
102860_at 1424923_at Serpina3g, serine (or cysteine) peptidase inhibitor, clade A, member 3G 3.05/2.08 ***
99476_at 1453931_at Col14a1, collagen, type XIV, alpha 1 2.95/(-)2.51
93013_at 1422537_a_at Id2, inhibitor of DNA binding 2 2.77/2.03 **
102293_at 1421303_at Ikzf1, IKAROS family zinc finger 1 (-)2.7/(-)2.2
99413_at 1419610_at Ccr1, chemokine (C-C motif) receptor 1 (-)4.13/2.62 *
The down-regulated transcripts are shown with "(-)"
* Denotes significant changes in Itk-/- T-cells. * p ≤ 0.05 ** p ≤ 0.01 *** p ≤ 0.001BMC Genomics 2009, 10:233 http://www.biomedcentral.com/1471-2164/10/233
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Additional File 3
106 immune response-related genes. The list of 900 probe-sets that were 
differentially expressed between unstimulated Itk-defective and Wt T-cells 
was used to manually annotate 106 immune response-related genes. The 
genes were further divided into 14 different subgroups. The down-regu-
lated transcripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S3.xls]
Additional File 4
252 differentially expressed probe-sets in Itk-deficiency compared to 
Wt after anti-CD3- and anti-CD3/CD28-stimulations of CD3+ T-
cells. All the comparisons were made against Wt and with the criterion   
2-fold. Only 5/252 probe-sets showed opposite fold-changes in anti-CD3- 
and anti-CD3/CD28-stimulations for 24 h. These genes are marked with 
*. The down-regulated transcripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S4.xls]
Additional File 5
3713 probe-sets overlapping upon anti-CD3- and anti-CD3/CD28-
stimulations in Wt CD3+ T-cells. 3713 differentially expressed probe-
sets overlapped in Wt CD3+ T-cells after both anti-CD3- and anti-CD3/
CD28-stimulations for 24 h. The comparisons were made against unstim-
ulated Wt (Wt C) and with the criterion   2-fold. The paired Student t-
test was used to calculate the p-values. The down-regulated transcripts are 
shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S5.xls]
Additional File 6
2393 probe-sets overlapping upon anti-CD3- and anti-CD3/CD28-
stimulations in Itk-defective CD3+ T-cells. 2393 differentially expressed 
probe-sets overlapped in Itk-/- CD3+ T-cells after both anti-CD3- and anti-
CD3/CD28-stimulations for 24 h. The comparisons were made against 
unstimulated Itk-/- (Itk-/- C) and with the criterion   2-fold. The paired 
Student t-test was used to calculate the p-values. The down-regulated tran-
scripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S6.xls]
Additional File 7
Eomesodermin and T-bet signal intensities. Bar charts showing the 
mean signal intensity (MSI) levels of Eomesodermin and T-bet in CD4+ 
and CD8+ T-cell populations (a and b) and in CD3+ T-cells (c and d) 
from Wt and Itk-deficient mice. Eomesodermin is represented by two 
probe-sets (grey and white bars). The two T-cell subsets are either unstim-
ulated or anti-CD3-stimulated, while the CD3+ T-cells are either unstim-
ulated, anti-CD3- or anti-CD3/CD28-stimulated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S7.tiff]
Additional File 8
324 differentially expressed probe-sets represent the core group of 
unstimulated Itk-defective CD4+ T-cells. The core group of probe-sets 
differentially expressed in unstimulated Itk-/- CD4+ T-cells (Itk-/- CD4+ C) 
compared to unstimulated Wt CD4+ T-cells (Wt CD4+ C). The compari-
sons were made with the criterion   2-fold. The unpaired Student t-test was 
used to calculate the p-values. The down-regulated transcripts are shown 
with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S8.xls]
Additional File 9
4467 differentially expressed probe-sets represent the core group of 
unstimulated Itk-defective CD8+ T-cells. The core group of probe-sets 
differentially expressed in unstimulated Itk-/- CD8+ T-cells (Itk-/- CD8+ C) 
compared to unstimulated Wt CD8+ T-cells (Wt CD8+ C). The compari-
sons were made with the criterion   2-fold. The down-regulated transcripts 
are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S9.xls]
Additional File 10
113 probe-sets being both Itk- and calcineurin-dependent upon anti-
CD3- and anti-CD3/CD28-stimulations in CD3+ T-cells. 113 probe-
sets are Itk- and calcineurin-dependent upon anti-CD3- and anti-CD3/
CD28-stimulations for 24 h. All the cells in the comparisons are CD3+ T-
cells. The comparisons were done using the criterion   2-fold and the p-
values were calculated using unpaired (for Itk-/- vs Wt) and paired (for Wt 
CsA vs Wt) Student t-tests. Cyclosporin A-treated samples are named CsA 
in the table. The down-regulated transcripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S10.xls]
Additional File 11
95 probe-sets being Itk-dependent and calcineurin-independent after 
anti-CD3- and anti-CD3/CD28-stimulations in CD3+ T-cells. 95 
probe-sets, corresponding to 89 transcripts, are Itk-dependent but cal-
cineurin-independent upon anti-CD3- and anti-CD3/CD28-stimulations 
for 24 h. The comparisons were done using the criterion   2-fold and the 
p-values were calculated using unpaired Student t-test. The down-regu-
lated transcripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-233-S11.xls]
Additional File 12
24 genes found in the bioinformatic searching for putative NFAT-
sites. The 24 genes were selected as highly regulated from the list compar-
ing Itk-/- anti-CD3- and Wt CsA anti-CD3-stimulated versus Wt anti-
CD3-stimulated samples. 15/24 genes had NFAT-sites and six of them 
were verified to bind NFATc1. The genes that have NFAT-sites are grey-
shaded and the genes verified to bind NFATc1 by chromatin-immunopre-
cipitation (ChIP) are in red. The genes marked with * are also found in 
the 113-list (Additional file 10) where genes are Itk- and calcineurin-
dependent after both anti-CD3- and anti-CD3/CD28-stimulation. The 
down-regulated transcripts are shown with "-".
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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